Published in Clin Infect Dis on February 01, 1996
Hazard ratio in clinical trials. Antimicrob Agents Chemother (2004) 2.95
The management of post-herpetic neuralgia. BMJ (2000) 2.04
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med (2010) 2.01
Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis (2010) 1.85
Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin Proc (2011) 1.20
Effect of viral load on the outcome of herpes zoster. J Clin Microbiol (2007) 0.95
Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia. J Virol (2013) 0.92
Management and prevention of herpes zoster: A Canadian perspective. Can J Infect Dis Med Microbiol (2010) 0.92
Postherpetic neuralgia in the elderly. Int J Clin Pract (2009) 0.90
The management of postherpetic neuralgia. Postgrad Med J (1997) 0.84
Prescription of antiviral therapy after herpes zoster in general practice: who receives therapy? Br J Gen Pract (2012) 0.83
Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity. Ophthalmology (2016) 0.78
Risk Factor and Prevention of Postherpetic Neuralgia. Korean J Pain (2015) 0.75
Prevention of shingles: safety and efficacy of live zoster vaccine. Ther Clin Risk Manag (2007) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science (1990) 6.70
Duplication of CaMV 35S Promoter Sequences Creates a Strong Enhancer for Plant Genes. Science (1987) 6.00
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis (2013) 4.51
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med (1986) 4.37
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28
Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet (1990) 4.12
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med (1991) 3.78
The natural history of herpes simplex virus infection of mother and newborn. Pediatrics (1980) 3.65
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med (1993) 2.98
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics (1980) 2.70
Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis (1982) 2.70
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery (1979) 2.65
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet (1988) 2.54
NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med (1978) 2.52
Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A (1987) 2.48
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41
Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum (1999) 2.39
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Intracranial stenosis in Chinese patients with acute stroke. Neurology (1998) 2.15
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med (1976) 2.09
Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med (1993) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Streptococcus suis meningitis. An important underdiagnosed disease in Hong Kong. Med J Aust (1983) 2.04
The management of post-herpetic neuralgia. BMJ (2000) 2.04
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A (2000) 1.99
A Markov model for analysing cancer markers and disease states in survival studies. Biometrics (1986) 1.97
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr (1992) 1.94
High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis (1991) 1.94
Expression cloning of oncogenes by retroviral transfer of cDNA libraries. Mol Cell Biol (1995) 1.89
A simple method for the detection of unstable haemoglobins. Br J Haematol (1972) 1.87
Validity of routine clinical test weighing as a measure of the intake of breast-fed infants. Arch Dis Child (1981) 1.84
Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones. Biochim Biophys Acta (1977) 1.84
Herpes simplex encephalitis. Clinical Assessment. JAMA (1982) 1.83
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
The Dbl-related protein, Lfc, localizes to microtubules and mediates the activation of Rac signaling pathways in cells. J Biol Chem (1999) 1.75
Hybrid pUC vectors for addition of new restriction enzyme sites to the ends of DNA fragments. Nucleic Acids Res (1987) 1.73
The analysis of failure time data in crossover studies. Stat Med (1991) 1.69
A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med (1990) 1.67
The prognostic significance of ulceration of cutaneous melanoma. Cancer (1980) 1.66
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1996) 1.66
Haemolytic-uraemic syndrome: an analysis of prognostic features. Arch Dis Child (1983) 1.64
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg (1982) 1.62
Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Stroke (1991) 1.61
Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med (2001) 1.60
Testis sparing surgery for pediatric epidermoid cysts of the testis. J Urol (1993) 1.57
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins. Gene Ther (1998) 1.57
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics (1981) 1.57
Expression cloning of lfc, a novel oncogene with structural similarities to guanine nucleotide exchange factors and to the regulatory region of protein kinase C. J Biol Chem (1995) 1.56
Lfc and Lsc oncoproteins represent two new guanine nucleotide exchange factors for the Rho GTP-binding protein. J Biol Chem (1996) 1.55
Vascular lesions in Chinese patients with transient ischemic attacks. Neurology (1997) 1.54
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis (1973) 1.54
Acyclovir kinetics after intravenous infusion. Clin Pharmacol Ther (1979) 1.52
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
Prepubertal varicoceles. Urology (1997) 1.51
Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation. J Infect Dis (1979) 1.50
Variability of magnetic resonance angiography and computed tomography angiography in grading middle cerebral artery stenosis. Stroke (1996) 1.50
Predictors of sun exposure in adolescents in a southeastern U.S. population. J Adolesc Health (1996) 1.50
Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol (1996) 1.48
Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med (1985) 1.47
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis (1983) 1.47
Syrinx and tuberculoma formation in tuberculous arachnoiditis. Can J Neurol Sci (2001) 1.47
The polymorphonuclear leucocyte count in childhood haemolytic uraemic syndrome. Pediatr Nephrol (1989) 1.46
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol (1983) 1.46
Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke (2000) 1.46
The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis (1992) 1.45
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res (1997) 1.45
Second-look laparotomy and salvage therapy: a research modality only? Gynecol Oncol (1992) 1.45
Needlescopic surgery for cryptorchidism: the initial series. J Pediatr Surg (2000) 1.45
A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg (1983) 1.45
Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group. J Infect Dis (1991) 1.44
Detection of antibodies to herpes simplex virus in the cerebrospinal fluid of patients with herpes simplex encephalitis. J Infect Dis (1987) 1.43
The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology (1997) 1.43
Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci U S A (1995) 1.41
ELISA for the detection of herpes simplex virus antigens in the cerebrospinal fluid of patients with encephalitis. J Virol Methods (1983) 1.41
The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc Natl Acad Sci U S A (1996) 1.41
Penile adhesions after neonatal circumcision. J Urol (2000) 1.41
Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J (1996) 1.41